[1] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol, 2019, 70: 172-193.
[2] Berzigotti A, Garcia-Tsao G, Bosch J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology,2011,54: 555-561.
[3] Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol,2016,65: 1232-1244.
[4] Tandon P, Raman M, Mourtzakis M, et al. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology,2017,65: 1044-1057.
[5] Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr,2020,39: 3533-3562.
[6] Oliveira KS, Oliveira LR, Fernandes SA, et al. Malnutrition in cirrhosis: association with etiology and hepatocellular dysfunction. Arq Gastroenterol,2020,57: 375-380.
[7] Kim G, Kang SH, Kim MY, et al. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One,2017,12: e0186990.
[8] 中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南. 中华肝脏病杂志, 2018. 26: 721-736.
[9] Ney M, Li S, Vandermeer B, et al. Systematic review with meta-analysis: Nutritional screening and assessment tools in cirrhosis. Liver Int, 2020, 40: 664-673.
[10] 中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南. 中华肝脏病杂志, 2019, 27: 330-342.
[11] Montano-Loza AJ, Angulo P, Meza-Junco J, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle,2016,7: 126-135.
[12] Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology,2013,58: 325-336.
[13] Nardelli S, Lattanzi B, Torrisi S, et al. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol,2017,15: 934-936.
[14] Montagnese S, Russo FP, Amodio P, et al. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis,2019,51: 190-205.
[15] Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology,2017,66: 564-574.
[16] Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol,2012,27: 430-441.
[17] Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol,2018,69: 1164-1177.
[18] 侯维, 王忠英, 董金玲, 等. 肠内营养及睡前加餐在肝硬化患者中的应用效果评价. 临床药物治疗杂志,2019,17: 33-37. |
